Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00383 | 35108454 | FEBS Open Bio | Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation. | 2022 | Details |
| A00387 | 35107488 | Arq Bras Cir Dig | OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES. | 2022 | Details |
| A00388 | 35106510 | Cell Rep Med | Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism. | 2022 | Details |
| A00390 | 35104757 | Phytomedicine | Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism. | 2022 | Details |
| A00392 | 35103461 | Minerva Endocrinol (Torino) | Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. | 2022 | Details |
| A00405 | 35098442 | Hepatol Int | Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review. | 2022 | Details |
| A00407 | 35096933 | Front Nutr | Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation. | 2022 | Details |
| A00409 | 35096868 | Front Med (Lausanne) | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. | 2022 | Details |
| A00412 | 35093608 | Mol Cell Proteomics | Integrated liver and plasma proteomics in obese mice reveals complex metabolic regulation. | 2022 | Details |
| A00416 | 35092912 | EBioMedicine | The influence of host genetics on liver microbiome composition in patients with NAFLD. | 2022 | Details |
| A00418 | 35092183 | Pediatr Obes | Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity. | 2022 | Details |
| A00420 | 35091821 | Diabetologia | Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice. | 2022 | Details |
| A00421 | 35091747 | J Nutr | Plasma Alkylresorcinol Metabolite, a Biomarker for Whole-Grain Intake, Is Inversely Associated with Risk of Nonalcoholic Fatty Liver Disease in a Case-Control Study of Chinese Adults. | 2022 | Details |
| A00428 | 35087774 | Front Pediatr | Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy. | 2022 | Details |
| A00430 | 35087037 | Cell Death Dis | Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function. | 2022 | Details |
| A00442 | 35082753 | Front Endocrinol (Lausanne) | Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
| A00447 | 35079935 | Mol Biol Rep | Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network. | 2022 | Details |
| A00453 | 35076162 | Hepatol Commun | Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin Adults. | 2022 | Details |
| A00455 | 35075592 | Hepatol Int | Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice. | 2022 | Details |
| A00459 | 35072848 | Inflammopharmacology | The effects of metformin, pioglitazone, exenatide and exercise on fatty liver in obese diabetic rats: the role of IRS-1 and SOCS-3 molecules. | 2022 | Details |
| A00460 | 35072542 | Antioxid Redox Signal | SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. | 2022 | Details |
| A00466 | 35070015 | World J Hepatol | Determination of "indeterminate score" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia. | 2021 | Details |
| A00470 | 35069992 | World J Hepatol | Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence? | 2021 | Details |
| A00476 | 35068681 | J Clin Biochem Nutr | A nutritional intervention that promotes increased vegetable intake in Japanese with non-alcoholic fatty liver disease: a six-month trial. | 2021 | Details |
| A00477 | 35068225 | Exp Biol Med (Maywood) | Impact of spexin on metabolic diseases and inflammation: An updated minireview. | 2022 | Details |
| A00481 | 35066992 | Liver Int | The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO). | 2022 | Details |
| A00488 | 35064452 | Indian J Gastroenterol | Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors. | 2022 | Details |
| A00489 | 35064417 | Qual Life Res | The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States. | 2022 | Details |
| A00496 | 35061665 | PLoS Biol | Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPARγ. | 2022 | Details |
| A00509 | 35057689 | Expert Rev Gastroenterol Hepatol | Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease. | 2022 | Details |
| A00516 | 35054924 | Int J Mol Sci | GLP-1a: Going beyond Traditional Use. | 2022 | Details |
| A00517 | 35054847 | Int J Mol Sci | The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00522 | 35053629 | Children (Basel) | Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index. | 2021 | Details |
| A00524 | 35053404 | Cells | Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver. | 2022 | Details |
| A00532 | 35052811 | Biomedicines | Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS). | 2022 | Details |
| A00534 | 35052763 | Biomedicines | Intestinal Barrier and Permeability in Health, Obesity and NAFLD. | 2021 | Details |
| A00536 | 35052726 | Biomedicines | Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. | 2021 | Details |
| A00551 | 35048923 | Food Funct | Feeding of cuticles from Tenebrio molitor larvae modulates the gut microbiota and attenuates hepatic steatosis in obese Zucker rats. | 2022 | Details |
| A00553 | 35048271 | Mol Biol Rep | Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice. | 2022 | Details |
| A00555 | 35047847 | HGG Adv | Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease. | 2021 | Details |
| A00558 | 35047114 | World J Diabetes | Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response. | 2021 | Details |
| A00559 | 35046901 | Front Endocrinol (Lausanne) | The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model. | 2022 | Details |
| A00575 | 35043830 | Sao Paulo Med J | Association between neck circumference and non-alcoholic fatty liver disease: cross-sectional analysis from ELSA-Brasil. | 2022 | Details |
| A00587 | 35038997 | BMC Public Health | Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study. | 2022 | Details |
| A00596 | 35035396 | Pak J Med Sci | Frequency of non-alcoholic fatty liver disease (NAFLD) and its associated risk factors among Type-2 diabetics. | 2022 | Details |
| A00601 | 35034646 | Lipids Health Dis | The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery. | 2022 | Details |
| A00606 | 35032545 | Metabolism | The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials. | 2022 | Details |
| A00613 | 35028685 | Calcif Tissue Int | Fatty Liver Index and Skeletal Muscle Density. | 2022 | Details |
| A00617 | 35027066 | Lipids Health Dis | Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. | 2022 | Details |
| A00627 | 35023202 | Hepatology | T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis. | 2022 | Details |
| A00633 | 35021063 | Cell | Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. | 2022 | Details |
| A00634 | 35021057 | Immunity | Inflammation in obesity, diabetes, and related disorders. | 2022 | Details |
| A00636 | 35020479 | Metab Syndr Relat Disord | Age- and Sex-Specific Differences in Distribution of Cardiometabolic Diseases and Associations of Hand-Grip Strength Indices with Type 2 Diabetes in Korean Adults. | 2022 | Details |
| A00637 | 35019905 | Biomater Sci | Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice. | 2022 | Details |
| A00639 | 35018737 | Hepatol Commun | Hepatocyte TGF-β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p. | 2022 | Details |
| A00640 | 35018684 | Phytother Res | Banana green peels extract protects against nonalcoholic fatty liver disease in high-fat-fed mice through modulation of lipid metabolism and inflammation. | 2022 | Details |
| A00643 | 35016856 | Obes Res Clin Pract | High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up. | 2022 | Details |
| A00651 | 35014161 | Diabetes Obes Metab | The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment. | 2022 | Details |
| A00656 | 35013417 | Sci Rep | Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver. | 2022 | Details |
| A00659 | 35011784 | J Clin Med | Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects. | 2021 | Details |
| A00667 | 35010923 | Nutrients | Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review. | 2021 | Details |
| A00668 | 35009003 | Int J Mol Sci | Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice. | 2022 | Details |
| A00669 | 35008925 | Int J Mol Sci | Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future. | 2022 | Details |
| A00671 | 35008682 | Int J Mol Sci | Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00676 | 35005800 | Aliment Pharmacol Ther | A sequential approach using the age-adjusted fibrosis-4 index and vibration-controlled transient elastography to detect advanced fibrosis in Korean patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A00677 | 35005749 | Food Funct | Protective effect of orange essential oil on the formation of non-alcoholic fatty liver disease caused by high-fat diet. | 2022 | Details |
| A00679 | 35005107 | Genes Dis | Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders. | 2021 | Details |
| A00682 | 35004947 | Hepatobiliary Surg Nutr | The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. | 2021 | Details |
| A00686 | 35003876 | Biomed Opt Express | Intravital two-photon imaging and quantification of hepatic steatosis and fibrosis in a live small animal model. | 2021 | Details |
| A00690 | 35002979 | Front Endocrinol (Lausanne) | Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. | 2021 | Details |
| A00692 | 35001468 | Pediatr Diabetes | Organ fat in Latino youth at risk for type 2 diabetes. | 2022 | Details |
| A00694 | 35000203 | Hepatology | Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. | 2022 | Details |
| A00697 | 34999330 | Clin Nutr | Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis. | 2021 | Details |
| A00698 | 34998993 | Clin Gastroenterol Hepatol | Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00703 | 34997159 | Sci Rep | Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease. | 2022 | Details |
| A00706 | 34994824 | Naunyn Schmiedebergs Arch Pharmacol | The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. | 2022 | Details |
| A00707 | 34993581 | J Mol Med (Berl) | A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants? | 2022 | Details |
| A00708 | 34993571 | Diabetologia | Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. | 2022 | Details |
| A00709 | 34993389 | Curr Dev Nutr | Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models. | 2021 | Details |
| A00713 | 34992541 | Front Pharmacol | Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling. | 2021 | Details |
| A00714 | 34992540 | Front Pharmacol | Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00718 | 34990729 | Toxicol Appl Pharmacol | Whole life exposure to low dose cadmium alters diet-induced NAFLD. | 2022 | Details |
| A00720 | 34990079 | Liver Int | Adherence to the dietary approaches to stop hypertension diet and non-alcoholic fatty liver disease. | 2022 | Details |
| A00722 | 34988994 | Aliment Pharmacol Ther | Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis. | 2022 | Details |
| A00723 | 34988895 | Obes Surg | Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States. | 2022 | Details |
| A00725 | 34988225 | Biomed Res Int | Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis. | 2021 | Details |
| A00737 | 34983637 | Diabetol Metab Syndr | Overweight/obesity in adolescents with type 1 diabetes belonging to an admixed population. A Brazilian multicenter study. | 2022 | Details |
| A00744 | 34981470 | Adv Exp Med Biol | The Effect of Herbal Medicine and Natural Bioactive Compounds on Plasma Adiponectin: A Clinical Review. | 2021 | Details |
| A00747 | 34981313 | Dig Dis Sci | Bariatric Surgery in NAFLD. | 2022 | Details |
| A00750 | 34980714 | J Nutr Sci Vitaminol (Tokyo) | Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00751 | 34980375 | Food Res Int | Exploring the potential mechanism of Rhodomyrtus tomentosa (Ait.) Hassk fruit phenolic rich extract on ameliorating nonalcoholic fatty liver disease by integration of transcriptomics and metabolomics profiling. | 2021 | Details |
| A00754 | 34979142 | Toxicol Appl Pharmacol | Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress. | 2021 | Details |
| A00756 | 34978351 | Aliment Pharmacol Ther | Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods. | 2022 | Details |
| A00758 | 34978141 | Obes Rev | Human microbiome and metabolic health: An overview of systematic reviews. | 2022 | Details |
| A00759 | 34977520 | JHEP Rep | Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. | 2021 | Details |
| A00764 | 34977118 | Front Nutr | Lactational High Fat Diet in Mice Causes Insulin Resistance and NAFLD in Male Offspring Which Is Partially Rescued by Maternal Metformin Treatment. | 2021 | Details |
| A00765 | 34975333 | Int J Biol Sci | Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential. | 2022 | Details |
| A00767 | 34974285 | Nutrition | Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis. | 2021 | Details |
| A00768 | 34974284 | Nutrition | Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease. | 2021 | Details |
| A00771 | 34973842 | Transplant Proc | Bariatric Surgery and Solid-Organ Transplantation. | 2021 | Details |